Publications

2021

  1. Tastula, A, Jukkola, A, Alakokkare, AE, Nordström, T, Eteläinen, S, Karihtala, P et al.. Early-life risk factors for breast cancer – prospective follow-up in the Northern Finland Birth Cohort 1966. Cancer Epidemiol Biomarkers Prev. 2021; :. doi: 10.1158/1055-9965.EPI-20-1442. PubMed PMID:33563646 .
  2. Karihtala, P, Jääskeläinen, A, Roininen, N, Jukkola, A. Real-world, single-centre prospective data of age at breast cancer onset: focus on survival and reproductive history. BMJ Open. 2021;11 (1):e041706. doi: 10.1136/bmjopen-2020-041706. PubMed PMID:33518519 PubMed Central PMC7852949.

Search PubMed

2020

  1. Erkinantti, S, Marttila, M, Sund, R, Arffman, M, Urpilainen, E, Puistola, U et al.. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes. Clin Colorectal Cancer. 2020; :. doi: 10.1016/j.clcc.2020.11.003. PubMed PMID:33279415 .
  2. Karihtala, P, Jääskeläinen, A, Roininen, N, Jukkola, A. Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital. BMJ Open. 2020;10 (10):e038798. doi: 10.1136/bmjopen-2020-038798. PubMed PMID:33046470 PubMed Central PMC7552835.
  3. Jääskeläinen, A, Roininen, N, Karihtala, P, Jukkola, A. High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study. Front Oncol. 2020;10 :1470. doi: 10.3389/fonc.2020.01470. PubMed PMID:32923400 PubMed Central PMC7457016.
  4. Hosio, M, Urpilainen, E, Hautakoski, A, Marttila, M, Arffman, M, Sund, R et al.. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study. Acta Oncol. 2020;59 (9):1110-1117. doi: 10.1080/0284186X.2020.1769858. PubMed PMID:32478629 .
  5. Myller, S, Ipatti, P, Jääskeläinen, A, Haapasaari, KM, Jukkola, A, Karihtala, P et al.. Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses. Acta Oncol. 2020;59 (9):1036-1042. doi: 10.1080/0284186X.2020.1760350. PubMed PMID:32394761 .

Search PubMed

2019
  1. Jääskeläinen, A, Jukkola, A, Haapasaari, KM, Auvinen, P, Soini, Y, Karihtala, P et al.. Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer. Anticancer Res. 2019;39 (11):5879-5890. doi: 10.21873/anticanres.13792. PubMed PMID:31704812 .
  2. Tiainen, L, Korhonen, EA, Leppänen, VM, Luukkaala, T, Hämäläinen, M, Tanner, M et al.. High baseline Tie1 level predicts poor survival in metastatic breast cancer. BMC Cancer. 2019;19 (1):732. doi: 10.1186/s12885-019-5959-8. PubMed PMID:31340773 PubMed Central PMC6657075.
  3. Jääskeläinen, A, Jukkola, A, Risteli, J, Haapasaari, KM, Karihtala, P. Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer. Tumour Biol. 2019;41 (5):1010428319847081. doi: 10.1177/1010428319847081. PubMed PMID:31122159 .
  4. Tiainen, L, Hämäläinen, M, Luukkaala, T, Tanner, M, Lahdenperä, O, Vihinen, P et al.. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clin Breast Cancer. 2019;19 (4):e522-e533. doi: 10.1016/j.clbc.2019.03.006. PubMed PMID:31029558 .
  5. Hosio, M, Urpilainen, E, Marttila, M, Hautakoski, A, Arffman, M, Sund, R et al.. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast Cancer Res Treat. 2019;175 (3):741-748. doi: 10.1007/s10549-019-05185-0. PubMed PMID:30895533 PubMed Central PMC6534663.

Search PubMed